Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Neuroblastoma”

344 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 344 results

Not applicableActive Not RecruitingNCT03057626
What this trial is testing

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Who this might be right for
Recurrent NeuroblastomaStage 2A NeuroblastomaStage 2B Neuroblastoma+3 more
Children's Oncology Group 376
Early research (Phase 1)Ended earlyNCT05429502
What this trial is testing

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

Who this might be right for
Neuroblastoma
Novartis Pharmaceuticals 12
Early research (Phase 1)Study completedNCT00509353
What this trial is testing

N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Hospital Los Angeles 26
Not applicableStudy completedNCT01850888
What this trial is testing

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Who this might be right for
Relapsed NeuroblastomaMetastatic Pheochromocytoma
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Looking for participantsNCT06803875
What this trial is testing

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-risk Neuroblastoma
Roberto Chiarle 42
Post-approval studies (Phase 4)Study completedNCT00336531
What this trial is testing

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
NeuroblastomaBrain TumorRetinoblastoma+2 more
Samsung Medical Center 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00486564
What this trial is testing

Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
University of Vermont 20
Testing effectiveness (Phase 2)Study completedNCT00002634
What this trial is testing

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 45
Early research (Phase 1)Study completedNCT00002730
What this trial is testing

Chemotherapy in Treating Children With Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Early research (Phase 1)Study completedNCT01576692
What this trial is testing

Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 34
Large-scale testing (Phase 3)UnknownNCT00410631
What this trial is testing

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
German Society for Pediatric Oncology and Hematology GPOH gGmbH 642
Early research (Phase 1)Study completedNCT02765243
What this trial is testing

Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma

Who this might be right for
NeuroblastomaEffects of Immunotherapy
Zhujiang Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Testing effectiveness (Phase 2)WithdrawnNCT02011126
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT00075634
What this trial is testing

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma

Who this might be right for
Recurrent NeuroblastomaUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 21
Not applicableNo Longer AvailableNCT02075177
What this trial is testing

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

Who this might be right for
Recurrent NeuroblastomaNeuroblastoma
South Plains Oncology Consortium
Early research (Phase 1)Study completedNCT01059071
What this trial is testing

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

Who this might be right for
Neuroblastoma
Giselle Sholler 21
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Load More Results